yingweiwo

Nanatinostat TFA

Alias: Nanatinostat TFATractinostat VRx-3996 TFA CHR 3996 VRx3996CHR-3996 CHR3996
Cat No.:V26223 Purity: ≥98%
Nanatinostat TFA (CHR3996 trifluoroacetic acid;Tractinostat; VRx3996) is a novel, oral, and hydroxamic acid-basedHDAC/histone deacetylase inhibitor (IC50 of 8 nM)with potential anticancer activity.
Nanatinostat TFA
Nanatinostat TFA Chemical Structure CAS No.: 1256448-48-2
Product category: New1
This product is for research use only, not for human use. We do not sell to patients.
Size Price
500mg
1g
Other Sizes

Other Forms of Nanatinostat TFA:

  • (Rac)-Nanatinostat
  • Nanatinostat
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Top Publications Citing lnvivochem Products
Product Description
Nanatinostat TFA (CHR3996 trifluoroacetic acid; Tractinostat; VRx3996) is a novel, oral, and hydroxamic acid-based HDAC/histone deacetylase inhibitor (IC50 of 8 nM) with potential anticancer activity. By inhibiting HDAC, Nanatinostat causes an accumulation of highly acetylated histones, the induction of chromatin remodeling, and the selective transcription of tumor suppressor genes, ultimately leading to the inhibition of tumor cell division and the induction of tumor cell apoptosis.
Nanatinostat TFA is a potent, orally active, class I-selective histone deacetylase (HDAC) inhibitor with molecular formula C19H20F3N5O2 and molecular weight 407.39 g/mol. It inhibits HDAC1, HDAC2, and HDAC3 with IC50 values of 3 nM, 4 nM, and 7 nM, respectively, and has an overall IC50 of 8 nM. Nanatinostat is a second-generation hydroxamic acid-based HDAC inhibitor with potential antineoplastic activity. It is used in research on cancer and inflammatory diseases.
Biological Activity I Assay Protocols (From Reference)
Targets
Nanatinostat is a class I-selective HDAC inhibitor that primarily targets HDAC1, HDAC2, and HDAC3. By inhibiting these enzymes, it causes accumulation of highly acetylated histones, leading to chromatin remodeling and reactivation of silenced tumor suppressor genes. This results in cell cycle arrest, differentiation, and apoptosis in cancer cells. Nanatinostat's selectivity for class I HDACs over class II HDACs may contribute to its therapeutic index and safety profile.
ln Vitro
Nanatinostat potently inhibits HDAC1, HDAC2, and HDAC3 with IC50 values of 3 nM, 4 nM, and 7 nM, respectively, and has an overall IC50 of 8 nM. It demonstrates class I selectivity over class II HDACs. In cellular assays, Nanatinostat induces histone hyperacetylation, leading to cell cycle arrest and apoptosis in cancer cell lines, including EBV-associated gastric cancer cells. These in vitro activities establish its potency and selectivity as an HDAC inhibitor.
ln Vivo
Nanatinostat is orally bioavailable and has been evaluated in preclinical animal models of cancer, including EBV-associated gastric cancer. It induces tumor growth inhibition and regression in xenograft models, correlating with histone hyperacetylation and modulation of gene expression. Nanatinostat has entered clinical trials for cancer and inflammatory diseases. Its oral bioavailability and brain penetration properties support its development for systemic and CNS-related conditions.
Enzyme Assay
For non-cell HDAC inhibition assays, recombinant HDAC1, HDAC2, or HDAC3 is incubated with a fluorogenic acetylated peptide substrate in the presence of Nanatinostat at various concentrations. Enzyme activity is measured by detecting the release of fluorescent product. IC50 values are calculated from dose-response curves.
Cell Assay
For cell-based assays, cancer cell lines are cultured in standard media and treated with Nanatinostat at various concentrations. Histone acetylation is assessed by Western blotting using acetylated histone antibodies. Cell viability is measured by MTT or sulforhodamine B assay. Apoptosis is assessed by flow cytometry using annexin V/PI staining or caspase-3 activity assays.
Animal Protocol
For in vivo antitumor studies, tumor xenografts are established in immunodeficient mice by subcutaneous implantation of cancer cells. Nanatinostat is administered orally at doses determined from pharmacokinetic studies. Tumor volume is measured regularly. Tumor tissues are collected for analysis of histone acetylation, gene expression, and apoptosis markers by immunohistochemistry and Western blotting.
References

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C22H20F4N6O4
Molecular Weight
508.43
Exact Mass
394.1554
CAS #
1256448-48-2
Related CAS #
914937-68-1 (racemic);1256448-47-1;1256448-48-2 (TFA);2648504-17-8 (hydrate); 1256448-48-2 (TFA); 1235859-13-8 (deleted);
PubChem CID
131888677
Appearance
Typically exists as solid at room temperature
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
13
Rotatable Bond Count
5
Heavy Atom Count
36
Complexity
675
Defined Atom Stereocenter Count
2
SMILES
C1[C@@H]2[C@@H](C2NCC3=NC4=C(C=C3)C=C(C=C4)F)CN1C5=NC=C(C=N5)C(=O)NO.C(=O)(C(F)(F)F)O
InChi Key
WNMHEOGBNZYJGD-MPSOVPLESA-N
InChi Code
InChI=1S/C20H19FN6O2.C2HF3O2/c21-12-2-4-16-11(7-12)1-3-13(24-16)8-23-18-14-9-27(10-15(14)18)20-22-6-5-17(25-20)19(28)26-293-2(4,5)1(6)7/h1-7,14-15,18,23,29H,8-10H2,(H,26,28)(H,6,7)/t14-,15+,18+
Chemical Name
2-((1R,5S,6s)-6-(((6-fluoroquinolin-2-yl)methyl)amino)-3-azabicyclo[3.1.0]hexan-3-yl)-N-hydroxypyrimidine-4-carboxamide trfluoroacetic acid
Synonyms
Nanatinostat TFATractinostat VRx-3996 TFA CHR 3996 VRx3996CHR-3996 CHR3996
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
Solubility (In Vivo)
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.

Injection Formulations
(e.g. IP/IV/IM/SC)
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)
*Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution.
Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)
Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil)
Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals).
View More

Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)]
*Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.
Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin → 500 μL Saline)
Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO → 100 μLPEG300 → 200 μL castor oil → 650 μL Saline)
Injection Formulation 7: Ethanol : Cremophor : Saline = 10: 10 : 80 (i.e. 100 μL Ethanol → 100 μL Cremophor → 800 μL Saline)
Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline
Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH → 900 μL Corn oil)
Injection Formulation 10: EtOH : PEG300:Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)


Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium)
Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose
Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals).
View More

Oral Formulation 3: Dissolved in PEG400
Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose
Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose
Oral Formulation 6: Mixing with food powders


Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 1.9668 mL 9.8342 mL 19.6684 mL
5 mM 0.3934 mL 1.9668 mL 3.9337 mL
10 mM 0.1967 mL 0.9834 mL 1.9668 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration: mg/mL;

Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Contact Us